Incidence of and survival following brain metastases among women with inflammatory breast cancer. (1/58)

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. (2/58)

Inflammatory breast cancer: the disease, the biology, the treatment. (3/58)

Mechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancer. (4/58)

Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapy. (5/58)

Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer. (6/58)

CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy. (7/58)

A global approach to inflammatory breast cancer. (8/58)

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8